Position in BBIO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$14,851,108
-$1,022,020 QoQ
Shares Held
199,988
-3.6% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 76.19057143428606.ToString("F0")%
Shared 0.ToString("F0")%
None 23.80942856571394.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AXIOM INVESTORS LLC /DE holds $88,046,456 across 7 Biotechnology names. BBIO ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
239,447 | $39,154,373 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
This page
|
199,988 | $14,851,108 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
56,529 | $9,554,531 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
85,475 | $9,009,065 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
91,749 | $7,979,410 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
99,568 | $5,789,879 | |
| 7 | VOR |
Vor Biopharma Inc.
|
95,745 | $1,708,090 |
All Filings in BBIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,851,108 | 199,988 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,873,128 | 207,519 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,708,050 | 109,897 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||